Therefore, the survival rate was poor in HNSCC patients with the GALNT14-rs9679162 non-TT genotype or the G allele, and the survival time of HNSCC patients with the GG genotype was short. This evidence concerns the gene GALNT14 and head and neck squamous cell carcinoma.